Innovating Immunology

We believe the immune system is a valuable tool that can be used to prevent and treat disease. We are developing immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology and its ability to modulate the immune system. We are focusing our TLR technology and expertise on addressing the challenges of infectious and inflammatory diseases and cancer.